Welcome to this 2021 series designed to help patients and caregivers understand the available treatment options for CLL across the continuum of care, learn about the details of BTK-inhibitor treatments, and confidently talk with their doctors and other clinicians to align their goals and priorities for care. View the modules in any order and return at any time. Please select a module to begin.
Completed
Module available on DATE
Module 1: Improving Chronic Lymphocytic Leukemia (CLL) Decisions Using BTK Inhibitors
Completed
Module available on DATE
Module 2: Aligning Patient and Provider Goals
Modules
Improving CLL Point-of-Care Decisions Utilizing BTK Inhibitors
Please select a module from the Modules menu.
